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Men and COVID-19: the aftermath  
 
White, Alan PhD RN  




The global pandemic as a result of the SARS-CoV2 virus has seen over 16m people 
infected and over 650,000 deaths, with men at double the risk of both developing the 
severe form of the disease and mortality. There are both biological (sex) and socio-
cultural (gender) factors, compounded by socio-economic factors and ethnicity, that 
impact on the aftermath of what has occurred over the short time that this novel 
coronavirus has been circulating the world.  
 
The potential life-long morbidity as a result of the infection and as a consequence of 
highly invasive critical care treatment needs to be factored into the rehabilitation of 
survivors. There are also many men whose lives will have been severely affected 
both physically and emotionally by the pandemic without ever contracting the 
disease, with the widespread disruption to normal existence and its impact on their 
social world and the economy.  The implications of the closure of many healthcare 
services over the initial lockdown will also have both a shorter- and longer-term 
impact on other diseases due to missed early diagnosis and disrupted treatment 
regimes. 
 
Getting effective public health messages out to the population is critical and this 
current pandemic is demonstrating that there needs to be a more focused view on 
men’s health behaviour. Without effective public support for preventative action the 
more likely the disease will continue its path unabated.  
 
This review explores the wider ramifications of the disease both for those men who 
have survived the disease and those that have been affected by the wider social 
effects of the pandemic. The pandemic should be a wake-up call for all involved in 
the planning and delivery of health and social care for the greater attention to the 





The current COVID-19 pandemic offers a prime example of how what we have come 
to know as ‘men’s heath’ is so much more than the biology of the reproductive 
system. Each disciplinary area will be focusing in on the implications of the disease 
but clinicians will also be seeing that the ramifications of the disease go beyond their 
own speciality. As we grapple with the numbers of men who have succumbed to 
severe illness and the high death rates the detailed exploration of the virus’s 
pathophysiology is being accompanied by equally exacting examination of the 
physical and emotional consequences of the disease and the social upheaval 
caused by the pandemic. With short, medium and long term effects that are going to 




This paper seeks to give a broad overview of the possible bio-medical (sex) and 
socio-cultural (gender) implications of the pandemic on men. Although this paper has 
been written from the point of view of men, there is an equally important need to 
consider the enormous impact the virus has had on women (1–4). There is now a 
worldwide effort being made to demonstrate the effect of the pandemic on women 
and men through such resources as GlobalHealth50/50 
(https://globalhealth5050.org) and Gender & Covid-19 (https://www.genderandcovid-
19.org). A key message is that that there are key sex/gender public health 
implications of the disease as we move towards the next phases of this disease that 
have to be taken into consideration and become a more central part of forward 
planning for future pandemics. 
 
At the time of writing this paper, late July 2020, there have been 16.34m confirmed 
cases and  650,805 deaths (5). Being male has been shown to be a particular risk 
factor for developing the severe form of the disease and mortality (2,6–10). A 
modelling exercise on the possibility of developing severe COVID-19 as a result of 
underlying health conditions suggests that 6% (225m) of the global male population 
may be at risk of requiring hospital admission if infected (3% / 123m females) (11). In 
the over 70 year olds an estimated 26% (52m) males and 14% (35m) females are at 
risk of hospitalisation. Their work was based on an assumption that men are at twice 
the risk as women of developing the severe form of the disease and the higher 
prevalence of non-communicable diseases in men. COVID-19 is again showing how 
biological sex and socio-cultural gender differences are differentially impacting on 
men to create the conditions for the disease to take its deadly toll (4,8).  
 
Men’s risk of SARS-CoV2 
 
How the disease affects the body is affected by the physiological environment of the 
individual this includes the underlying pathway the virus takes to invade the host 
cells, the reaction of the host to the virus, and co-morbidities that influence the 
impact of the disease – all of which can be seen to have marked biological sex 
differences (12). These have been well described elsewhere (13–19) 
 
Beyond the biological risk the epidemiological evidence of the spread of the disease 
is demonstrating that this is not an equal playing field, with marked intersectional 
differences seen in its impact based on different population groups (20). Men’s risk 
of developing and dying from SARS-CoV2 is markedly increased depending on their 
socio-economic status. In England and Wales, males in the least deprived areas 
have a death rate of 77.6 per 100,000 (44.3 per 100,00 for females) rising to 172 per 
100,000 in the most deprived areas (97 per 100,000 for females) (21). The disease 
has also been seen to hit those from non-white ethnicity harder (22,23). Of the 
10,075 patients who have been through intensive care in England, Wales and 
Northern Ireland by the 16th July 2020 4,654 were White ethnicity males and 2,411 
were non-White ethnicity males [1,999 White ethnicity females, 1,004 non White 
ethnicity females], which represents a higher proportion than seen within the overall 
demographics for the countries (24).  
 
There is a strong link between poverty and the high levels of mortality in non-White 
ethnicities, representing 62% of all male patients in intensive care living in the lowest 
two quintiles of deprivation (as compared to 44.7% for White ethnicity) (24). In an 
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analysis into the clinical risk factors against demographic profiles for the first 5,683 
deaths in England the risk posed by deprivation and by race was not explained by 
higher rates of ill-health or other clinical risk factors, suggesting that it was more 
related to local social and environmental issues (25), such as living in crowded 
areas, poorer housing, a lack of accessible health care, and be employed in more 
risky settings (22,26–28). There also higher levels of co-morbidity associated with 
the severe forms of the disease, such as cardiovascular disease, diabetes and 
obesity in men of non-White ethnicity (23,29,30). Such that the compounding of risk 
factors in most deprived communities may result in the negative aftermath of the 
pandemic also being borne by those with the least resources to manage(20). But this 
does not explain all the vulnerability (31), and it is worrying to note that an early 
review of deaths in health care workers in the UK found 94% of the deaths in doctors 
were male and that 94% of the deaths in medical staff were non-White ethnicity (32). 
 
Men’s health behaviour 
 
The pandemic is demonstrating that the different way men and women respond to 
public health messages and risk is an area that needs urgent consideration. This 
pandemic has hit at the core of most people’s existence, creating for many an 
existential threat to their identity and their place in the world. Classic depictions of 
masculinity include notions of control, independence, power over others, pride, inner 
strength, competitiveness, success, and self-control (33,34), with a recognition of its 
dynamic nature, affected by personal, contextual and cultural factors, but all of which 
impacted upon by the pandemic.  
 
Getting men to change their behaviour is a challenge with some studies suggesting 
that older men are less worried by the disease and more resistant to adopting 
preventative measures than younger men (35). This may be due to better emotion-
focused coping skills or a reduced perception of risk, which given the higher rate of 
death in older men is problematic. In a survey conducted by YouGov on British men 
and women found nearly a quarter of British men (24%) inaccurately believe 
coronavirus is ‘just like the flu’ compared with 16% of women. Similarly, they are 
also less inclined to believe official Government advice such as staying inside to 
stop the virus from spreading, with 10% saying this is false compared with 2% of 
women (36). 
 
There are also signs that young men are also resistant to change, with a greater 
likelihood of breaking social distancing rules, with two-thirds of those fined in 
England and Wales for breaking lockdown were under 35 years of age and of those 
fined eight out of ten were male (37). The wearing of a mask has been is now being 
put forward as an important means of managing the spread of the disease, however 
there are reports that men are being put off by the effect it will have on their image. 
In a study of 1,266 males and 1,183 females in the USA on their willingness to wear 
a mask more men agreed that it would be shameful, not cool, a sign of weakness, 
and a stigma (38).  
 
Similarly, hand hygiene has been found previously to be more thorough and 
performed more regularly by women as compared to men, both generally (39) and 
more specifically during the H1N1 outbreak (40) and the 2003 SARS epidemic (41). 
Early indications suggest that this is the same finding for the current pandemic. In a 
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study from China compared with males, females more frequently washed their hands 
(OR 2.39, 95% CI 1.85-3.09, P < .001) (42). Other behavioural factors were also 
found in this study as women were more likely to: cover their nose and mouth when 
sneezing and coughing (OR 2.12, 95% CI 1.63-2.74, P < .001), keep social distance 
with others (OR 1.64, 95% CI 1.28-2.11, P < .001), stay home (OR 1.34, 95% CI 
1.05-1.70, P = .02), avoid using public transportation (OR 2.30, 95% CI 1.72-3.07, P 
< .001), and clean frequently touched surfaces (OR 1.58, 95% CI 1.25-2.00, P < 
.001). Again, this can be linked to both a health awareness issue, but also one 
related to their sense of self: “[the disease] they can’t fight back against, they look for 
some way to assert their masculine gender identity, in this case by proclaiming that 
they don’t need to wash their hands, that they’re tough enough to resist the disease 
without taking any steps.” (43) 
 
Men tend to have higher levels of smoking globally(44), with its implications on 
NCDs such as cancer(45), CVD(46) and respiratory disease(47) well recognised. 
There have been welcome signs that in many countries the prevalence of smoking 
has been declining, however this progress may have been affected by the pandemic.  
There have been conflicting reports on whether either current or previous smoking 
behaviour has contributed to COVID-19 risk. Some studies have suggested it has 
increased the risk (48–50), others that there is a relative absence of smokers from 
those with the severe form of the disease (48,51–53). The overall consensus is that 
smoking is both associated with increased risk of developing severe disease and 
death (54,55). However, the conflicting advice may have contributed to an increased 
uptake of smoking. This is coupled with the emotional stress of the pandemic and 
also for many the loss of inhibitory factors such as smoke free workplaces along with 
reduced access to smoking cessation services and vaping products (56–58).  
 
Alcohol intake has also been a significant factor in men’s higher risk of NCDs and 
wider physical and emotional health problems (59,60). It’s been suggested that there 
has been an overall reduction in consumption due to closure of restaurants and bars 
as a result of the lockdown (61). However consumption has shifted to the home, 
which may have added to the increased reporting of domestic violence incidents 
(62). Rhem and colleagues also warn that the changes that have been introduced 
with regard to policy changes to help give easier access to alcohol may not be 
reversed, increasing availability (61). A further important factor is in regard to those 
who receiving support due to alcohol dependency may have regressed with loss of 
service provision (62). 
 
Obesity has one of the most common morbidities seen in severe cases of SARS-
CoV2, with 73.7% of patients admitted to intensive care in England, Wales and 
Northern Ireland having a BMI >25 (24). Men have a higher proportion of their body 
fat as the more metabolically active visceral fat (63), which also has a more active 
role in leptin production and the inflammatory response through a higher ACE2 
expression (64). Visceral fat is associated with the metabolic syndrome and the 
development of Type II diabetes, which are also both highly implicated in severe 
forms of the virus infection (65,66). Viral shedding is greater in obese patients, due 
to storage of the virus in adipose tissue, suggesting that there should be longer 
convalescence and social distancing (67). [Extended virus shedding was also 
reported in men generally in a study from China (18)]. It will be important as we 
move forward to assess how the lockdown has impacted on food consumption and 
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what public health initiatives can be supported to start to tackle the increasingly 
obesogenic male population.  
 
Longer term health implications for men 
 
According to the intensive care national audit and research centre (ICNARC) as of 
the 17th July 4,133 males (1934 females) have been discharged alive from ICU in 
England, Wales and Northern Ireland (24), these men and women may be expected 
to have life-long repercussions, both as a direct consequence of the disease and as 
a result of the intensive care experience they have endured. There will be layers of 
complex physical and emotional sequalae that may occur that poses severe long 
term challenges to the man, his family and the health and social care services.  
 
The Post Intensive Care Syndrome is being highlighted as an important factor in 
those who have survived intensive therapy   
 
------------------- 










Post-traumatic stress disorder 
Physical impairments 
Dyspnea/Impaired pulmonary function 
Pain 
Sexual dysfunction 






As many will have entered into their critical phase whilst already suffering from one 
or more co-morbidities, be more likely to be obese, and be elderly their rehabilitation 
will be more challenging (69,70). One of the main features of the SARS-CoV2 virus 
is the complexity of the disease and the widespread effect it can have throughout the 
body. This can leave a legacy of health problems in survivors that goes beyond 
those seen in the SARS and the MERS epidemics (71).  
 
To be expected, the virus infection is associated with extensive lung damage, 
especially in those that have developed the acute respiratory distress syndrome 
(ARDS) and acute lung injury (ALI), both of which have a high mortality rate. A 
Belgium study CT study of 216 confirmed COVID-19 patients, which involved the 
scoring of lung damage found that there were no differences between age or time 
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from onset of the disease, but that men had more extensive lung damage (9.2±5 
versus 7.0±4.8, p=0.001) with a trend toward more bilateral lung involvement (89.3% 
versus 78.8%, p=0.06) (72). Even for those who do not go on to develop ARDS or 
ALI there can be residual pathology, including alveolar damage and fibrosis that will  
compromise lung function in the longer term (73–75).  
 
The disease has been noted as causing significant cardio-vascular damage, through 
the exacerbation of existing cardiac morbidity and through the consequences of 
direct viral damage, acute thromboembolism, hypoxic injury, indirect injury as a 
result of inflammation, myocardial ischemia / infarction as a result of plaque rupture, 
and heart failure (76,77).  
 
Recently, thyrotoxicosis, owing to a form of silent subacute thyroiditis, has been 
found in a group of COVID-19 patients referred to as High Intensive Care in a single-
center study. Interestingly, about 70% the patients were males, indicating that the 
male genetic background and the hormonal milieu (testosterone) might play a key 
role in this autoimmune disease, even though it is generally more frequent in females 
than in males (78). 
 
There has also been significant neurological morbidity as a result of the virus, both 
as a result of direct neuro-invasion through the high ACE2 expression within the 
nervous system allowing the virus to cross the blood brain barrier and direct entry via 
the olfactory bulb and vagus nerve (79,80). The symptoms can including stroke, 
seizures, headache, dizziness, delirium, hypogeusia and hyposmia (81–83). There 
have also been 11 confirmed cases of Guillain-barre syndrome (83). In a prospective 
study in Italy that explored subjective neurological symptoms (sNS) in 103 
hospitalised patients 54 out of 59 men (91.5%) and 40 out of 44 women (90.9%) 
reported at least one sNS (84). The most frequent symptoms were sleep impairment 
(51/103; 49.51%); dysgeusia (48/103; 46.60%), headache (40/103; 38.83%), 
hyposmia (40/103; 38.83%), and depression (39/103; 37.86%). 
 
The neurological consequences of long-stay hospital admissions also have to be 
considered. These will include the possibility of polyneuropathy/myopathy (83) and 
the neurological damage that may have occurred as a result of cerebral hypoxia, 
including cognitive impairment, personality and behavioural changes that can impact 
on a person’s personality and ability to return to their prior lives (85,86).  
 
There may be other long term implications as a result of the impact of the virus on 
the gastro-intestinal system (87) and renal damage (88,89).  Those patients coming 
through an intensive care experience may also be at risk of developing chronic pain, 
both as a consequence of the physically demanding nature of therapy and the 
potential neurological sequalae of the infection (90). There is also the risk of 
Intensive care unit-acquired weakness (ICUAW), which can result in severe long 
lasting disability (75). In addition, fatigue is emerging as a particular problem, both 
for those who have milder forms of the disease and those who have had disease 
warranting intensive care treatment (91–93). Although too soon to be formally 
diagnosed as chronic fatigue syndrome there are growing reports of symptoms 
similar to Myalgic encephalomyelitis (ME) as part of a post-viral response, with a 
similar picture to those seen in previous epidemics (94,95). Debilitating levels of 
fatigue, which has a substantial impact on quality of life, is also found as part of the 
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post intensive care syndrome (96), and with the number of men who have had 




With ACE2 being highly expressed within the testes (both in the Ledig cells and in 
the seminiferous ducts), there is the potential risk of fertility being affected (97,98), 
which will need to be assessed, especially those that had an associated viral orchitis 
(88). Nevertheless, although it has been reported that the previously existing 
coronavirus which causes severe acute respiratory syndrome (SARS), and other 
viruses such as HIV, HBV, and mumps enter into the testes and cause viral orchitis 
and perhaps even infertility (99), specific orchitis due to COVID 19 has yet to be 
observed. Also, too few studies, even those consisting of a low number of 
participants, have been carried out to evaluate the presence of SARS-CoV2 in 
seminal plasma. However, one study has found the virus in semen (100), whilst  
others (101,102) did not demonstrate any viral RNA material in the semen fluid, 
questioning the role of seminal fluid as a transmission route of that infection (103). Of 
note, one study has suggested that the testes may act as a reservoir for the virus, 
adding to the delay in clearing the body of the disease (104).  
 
In a study of the impact of SARS-CoV2 on the male sex hormones, 81 reproductive-
aged infected men were compared to 100 control un-infected men. There was no 
statistically significant change in serum testosterone (T), however a significant 
increase was seen in serum luteinizing hormone (LH) and ‘dramatically decreased’ 
ratios in both T to LH and also follicle stimulating hormone (FSH) to LH (105). 
Suggesting that the virus may be having a direct gonadal influence.  
 
Low testosterone has been linked to a higher risk of mortality generally (106) and 
more specifically in the H7N9 influenza epidemic (107) and has been suggested as a 
cause of severe disease and increased mortality in this current COVID-10 pandemic 
(108–111). The measurement of testosterone levels is not routinely undertaken and 
therefore there is little empirical evidence of its impact, with currently only one small 
scale study of 31 patients demonstrating an increased risk (108). Such that this link 
remains mostly a hypothesis based on the already recognised negative effect of low 
testosterone on recognised pre-existing morbidity such as epithelial dysfunction and 
cardiovascular disease, the risk of obesity; and the metabolic syndrome (109,112–
114). There may also be an association with the immune response to the virus, 
through an association with increased pro-inflammatory cytokines (115). Interestingly 
an Italian study exploring the extent of COVID-19 in men undergoing prostate cancer 
therapy found those on androgen-deprivation therapy (ADT) had a lower risk of 
SARS-CoV2 than those not on ADT (116). It has been suggested that greater 
attention should be made to the role of testosterone deficiency in the severity of the 
disease and the possible beneficial effect of phosphodiesterase type 5 (PDE5) 
inhibitors (12,117–119). 
 
Sexual behaviour has been found to be altered during the pandemic, with a 
reduction in sexual desire and number of sexual partners during the lockdown, with a 
concomitant reduction in sexually transmitted infections as a result of anxiety, fear, 
boredom and disappointment, coupled with the physical restrictions posed by closing 
down of movement (120,121) . Men in a study from China were found to have had a 
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53% decrease in the number of sexual partners (30% for females) and 32% of men 
and 39% of women experienced a reduction in sexual satisfaction (120). The authors 
warn that there 32% of men and 18% of women reported that they would increase 
the number of sexual partners or risky sexual behaviours once the epidemic ends.  
 
An online survey was conducted in the USA between April 10 to May 10, 2020 of 
1,968 LGBTQ individuals, including 728 gay and bisexual men of the impact of 
COVID-19 on their sexual behaviour (121). For the gay and bisexual men there was 
a marked change reported in their sexual behaviour and partner selection, with nine 
out of ten having just one sexual partner or no sexual contact within the previous 30 
days. However, only 40% would disclose they had symptoms and as restrictions 
were easing with the authors note with concern that safeguarding strategies adopted 
during the lockdown may be stopping.  
 
In recent years there has been welcome progress made on the management of HIV 
within the community. Two studies with gay men and men who have sex with men 
are showing that there were worries that the disruption in testing, prevention and 
treatment services may start to see more men who have sex with men (MSM) 




In times of pandemics and other international and national pressure points there has 
been a concomitant increase in reported mental health problems and suicide. In 
2009, Mak et al (124) called the 2003 SARS epidemic a ‘mental health catastrophe’ 
due to the long-term psychological morbidity that followed. Their study, and others 
(124–127) all reported high levels of persistent anxiety and depression, along with 
increased susceptibility to post traumatic stress disorder. For those who required 
intensive therapy during the 2009 Influenza A(H1N1) pandemic at 1 year follow 
survivors were more likely to report psychiatric effects than matched control group. 
With those needing extracorporeal lung assist and those who did not need that level 
of support demonstrating severe anxiety symptoms (50% & 56%), with 28% in each 
group with severe depression symptoms, and five (41%) and 11 (44%) deemed at 
risk for PTSD(128).  
 
Alongside the neuropsychiatric symptoms noted above there is an increased risk that 
those who have been admitted to hospital will experience post-traumatic stress 
disorder (PTSD). Through both the overwhelming experience of critical care and a 
consequence of the fear of dying (68,70,71,129). These studies were focused onto 
survivors of the severe forms of the disease, but there are wider ramifications of the 
pandemic due to its widespread impact on all aspects of life, with the social and 
economic impact threatening nearly every aspect of an individual’s existence 
(130,131).  
 
The economic consequences and long term financial insecurity as a result of the 
pandemic is far greater than seen in recent history, with previous economic 
depressions and recessions being shown to have a significant impact on the mental 
health of men and a marked rise in suicides (132–134). There have also been 
reports of increased gambling (135,136), which may add to family’s financial 
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difficulties and have a negative effect on those under support for pathological 
gambling.  
 
Studies that have explored time usage have demonstrated that the time spent on 
childcare and household activities is usually higher for women than it is for men 
(137), with men who are employed more often working full time, working longer 
hours and more likely to commute longer distances to work(138,139). All of these 
factors will have been affected by the lockdown, closure of work, restrictions on 
travel and the high rates of job losses and the pending recession. For some men the 
pandemic has helped redefine their identity as a father, worker and as a partner, for 
others it may have cemented existing patterns of behaviour, built on notions of 
regaining control or defiance against a shifting social and economic backdrop. A very 
negative consequence of the pandemic has seen an increase in reports of domestic 
abuse and intimate partner violence (3), this has left both female and male victims 
with little opportunity to escape the perpetrator.  
 
Male socialisation and societies expectations on how boys and men are expected to 
manage their emotions can impact on the way they present mental and emotional 
difficulties (140–145). Men are more likely to externalise their difficulties, such as 
through anger, alcohol / substance abuse, increased risk taking as compared to 
women who are more likely to internalise and have signs and symptoms more 
associated with traditional diagnostic tools of anxiety and depression(140,146).  
 
Tensions within the close confines of a house during the lockdown, with no means of 
escape may also precipitate a rise in separation and divorce as a result of 
relationship breakdown (147). With the high death rate there will also be an increase 
in men facing widowhood. The gendered impact on men’s mental and physical 
health through social isolation and loneliness is being more widely reported on (148), 
with an increased risk of premature death, suicide, and worsening mental health. 
 
Although the virus has not inflicted as widespread direct infection related harm to 
many children and young adults as seen in older adults there may also be both 
shorter and longer term negative emotional health consequences to boys through 
their disrupted boyhood, stressful home events, fear, and lost education as a result 
of the lockdown (149).  Boys find it difficult to process stressful experiences and to 
express their emotions (150). The enforced period of home confinement separating 
them from their friends and wider social world at a time when for many they were just 
gaining a sense of independence and self. Loss of school will also mean for many of 
the most vulnerable (including those who are gay, bisexual, drug users) the loss of 
critical services and a safe and nurturing environment  and linked with depression, 
self-harm, attempted suicide. (149,151). For boys there have also been warnings 
about the increase in male muscularity-orientated disordered eating and exercise 
(152). 
 
Through the pandemic there has been an unprecedented shutting down of nearly all 
competitive sport worldwide, with the concomitant loss of a key aspect of many 
men’s lives. Both playing and spectating sport provides many men with both a 
mental and emotional release and is a key aspect of their social networking (153), 
what short and longer term impact this will have had on their health is yet to be seen, 
but for some it could be substantial.   
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Moukaddam (154), in a prescient article published just a month before COVID-19 
emerged, explored the psychological impact of pandemics.  He categorised these 
under three areas, all of which are emerging as the pandemic unfolds:  
 
• New onset symptoms 
o Adjustment/depression/anxiety versus well defined postinfectious 
manifestations (such as post-measles subacute sclerosing 
panencephalitis [SSPE] and Paediatric autoimmune neuropsychiatric 
disorders associated with Streptococcus infections [PANDAS]) 
• Worsening of existing conditions 
o Exacerbation of existing mood, psychotic or addictive disorders 
• Effect on caretakers and friends/family 
o Depression/anxiety versus stigma, shaming 
 
For those with existing mental health conditions, and for those whose mental health 
has deteriorated through the pandemic, the closure of general medical provision and 
psychological support services (including those for anorexia, self-harm, alcohol and 
drug dependency services) will have left many very vulnerable to further 
deterioration. There has been a considerable effort to develop on-line and telephone 
support services, which may provide important short term relief, but longer term 
planning for increase in demand in counselling and psychiatric service provision is 
needed (131,155). 
 
It is important to also note the health and social care sector is working under 
enormous pressure, from those on the front line to researchers trying to find cures to 
those trying to coordinate stretched services. The mental health strain of the staff 
has been immense with already reports of staff succumbing to the stress, as was 
also seen during the previous pandemics (156).  
 
Wider health effects 
 
In the UK there has been a marked rise in deaths other than for COVID-19, as 
compared to the five year average for deaths at this time of year with male deaths 
exceeding female deaths in the younger years and a female excess in the over 80 
years (157). Some of these deaths may be as a result of COVID-19, but masked by 
other co-morbidities, but it may also be a consequence of people being unable, or 
unwilling, to seek medical help.  
 
There has been a reported 57% reduction in Accident & Emergency visits in the UK 
comparing April 2020 to April 2019 (158), with 48% reduction in major A&E units. 
This may be a result of reduced need (such as fewer work-related and road traffic 
accidents, less pollution related ill-health, fewer transmitted infections). However, the 
reports that the very quiet Accident & Emergency departments, clinics and surgeries 
may also mean that many preventable deaths are being missed. There was 
reluctance seen in patient’s both for not willing to put extra strain on the services, but 
also through fear of contracting the virus whilst in clinical premises. Family doctors 
have had to find new ways of holding consultations, with many turning to phone calls 
and the use of internet video – it will be important to see if there how these new 
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services have been used by men and whether they have improved their health 
seeking behaviour.   
 
There is also going to be a long term consequence of missed appointments and 
treatment through the widespread closure of clinics, shutting down of screening 
programmes, cancelling of routine operations, rapid emptying of hospitals to clear 
space for the feared influx of COVID-19 patients. An ONS report for England & 
Wales cites ischaemic heart disease and other forms of circulatory disease, stroke, 
sepsis, meningitis, appendicitis, asthma and diabetes as contributing to the excess 
deaths. The data is not yet sex-disaggregated, but with men having a greater risk of 
heavy impact disease (159) they are at particular risk. Reduced hospital capacity 
may also have a role to play as planned treatments were delayed and more men 
have life-limiting diseases in their younger years, such as cancer and cardio-vascular 




What the current pandemic has revealed is that the world was not prepared to deal 
with such a new disease and we are in uncharted territory. Men’s vulnerability 
demonstrates that there are biological as well as socio-cultural factors at play and 
whilst there have been a higher number of men getting the severe form of the SARs-
CoV2 virus a greater proportion have not had it, but we are all affected by the 
pandemic.  
 
With this being such a complex disease the aftermath for those who survived the 
severe disease will have to face a long rehabilitation, with many having life-changing 
morbidity, both physical and emotional. Few of those who have not had the disease 
will remain unaffected by the impact of the closure of much of society with the 
serious impact on the economy and on our social world. The emotional impact of the 
lockdown and the longer term emerging recession coupled with the complex grieving 
many will be experiencing will result in high mental health burden and increased 
rates of suicide in men.  
 
Careful planning is now needed to get supportive measures in place for those who 
are our most vulnerable, especially as it is inevitable that this virus will be with us for 
many years to come. However, this work is hampered by the historical lack of policy 
focused onto men’s wellbeing, such that the groundwork that is needed to reach out 
effectively to men has not been done (162,163). We need a concerted effort to help 
men get onto the road to recovery both as a patient and also as a member of a 
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